Plants traits introduced by Crispr gene editing will be subject to the same lengthy regulatory process as 1980s-style genetically modified organisms containing genes from other species, Europe’s highest court rules
The IMI Stakeholder Forum 2018 will take place on Wednesday 24 October in Brussels, Belgium. The theme this year is ‘The value of cross-sectoral health research and innovation’, and discussions will focus on the added value of technology convergence to address complex health challenges, especially in those areas where there is huge public health need.
An Antimicrobial Resistance (AMR) Accelerator Programme is part of new IMI Calls for proposals, along with topics on brain disorders, immune-mediated diseases clinical trial design, medicines safety, and blockchain technologies.
Call them what you will: change makers, thought leaders, people who get stuff done. This is the Science|Business guide to those with the most influence over the size and shape of the EU’s next research programme
At the Euroscience Open Forum conference, a Bulgarian medical start-up demonstrates the potential - and the challenges - of getting health systems to focus on preventing disease, rather than responding when it strikes